plerixafor has been researched along with Fanconi Anemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broxmeyer, HE; Chen, S; Ciccone, SL; Clapp, DW; Hobson, MJ; Li, Y; Pulliam, AC; Srour, EF; Yang, FC | 1 |
1 trial(s) available for plerixafor and Fanconi Anemia
| Article | Year |
|---|---|
Phase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the FANCA Gene: A Coordinated International Action (EuroFancolen).
Topics: Animals; Benzylamines; Cyclams; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; International Cooperation; Lentivirus; Mice, Knockout; Orphan Drug Production | 2015 |
1 other study(ies) available for plerixafor and Fanconi Anemia
| Article | Year |
|---|---|
AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice.
Topics: Animals; Benzylamines; Bone Marrow Transplantation; Cells, Cultured; Colony-Forming Units Assay; Cyclams; Drug Synergism; Drug Therapy, Combination; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group C Protein; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Knockout; Peripheral Blood Stem Cell Transplantation; Radiation Chimera; Transplantation, Homologous | 2008 |